Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-09-15
1997-11-18
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 165, 534 10, 534 14, 530326, 530300, A61K 5100, A61M 3614
Patent
active
056884893
ABSTRACT:
Detectably labelled non-receptor mediated cell-associating compounds are provided for use in the diagnostic imaging of target sites in a mammal. Cell-associating compounds may be directly labelled, or labelled via a chelating compound to form a conjugate. Such cell-associating compounds are particularly useful to image target sites such as tumour sites and sites of infection.
REFERENCES:
patent: 4810777 (1989-03-01), Zasloff
patent: 5091514 (1992-02-01), Fritzberg et al.
patent: 5480970 (1996-01-01), Pollak et al.
patent: 5491074 (1996-02-01), Aldwin et al.
du Preez et al. Technetium in Chemistry & Nuclear Medicine, 1986, vol. 2, pp. 85-95 "Spectroscopic studies on the interaction of the antibiotic lasalocid A (X-537A) with technetium (V) ions in methanol".
Duclohier Toxicology, 1994, 87:175-188 "Anion pores from magainins and related defensive peptides".
Kimbrell BioEssays, 1991, 13(12):657-663 "Insect Antibacterial Proteins: Not Just for Insects and Against Bacteria".
Gabay Science, 1994, 264:373-374 "Ubiquitous Natural Antibiotics".
Boman et al. FEBS Letters, 1989, 259(1): 103-106 "Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids".
Zasloff Current Opinion in Immunology, 1992, 4:3-7 "Antibiotic peptides as mediators of innate immunity".
Chen et al. FEBS Letters, 1988, 236(2): 462-466 "Synthetic magainin analogues with improved antimicrobial activity".
Wade et al. Proc. Natl. Acad. Sci. USA, 1990, 87: 4761-4765 "All-D amino acid-containing channel-forming antibiotic peptides".
Cruciani et al. Proc. Natl. Acad. Sci. USA, 1991, 88: 3792-3796 "Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation".
Christensen et al. Proc. Natl. Acad. Sci. USA, 1988, 85: 5072-5076 "Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes".
Duclohier et al. Biophys. J. 1989, 56: 1017-1021 "Antimicrobial peptide magainin i from Xenopus skin forms anion-permeable channels in planar lipid bilayers".
Barnett et al Nucl. Acids Research, 1990, 18(10):3094 "Rapid generation of DNA fragments by PCR amplification of crude, synthetic oligonucleotides".
Wosnick et al Gene, 1989, 76:153-160 "Total chemical synthesis and expression in Escherichia coli of a maize glutathione-transferase (GST) gene".
Arya et al Bioconjugate Chem. 1991, 2, 323-326 "Rapid Synthesis and Introduction of a Protected EDTA-like Group during the Solid-Phase Assembly of Peptides".
Andre et al FEBS Letters, 1992, 296(2): 190-194 "Shortened cecropin A-melittin hybrids, Significant size reductioin retains potent antibiotic activity".
Maloy et al (1995). Biopolymers (Peptide Science), vol. 37, No. 1, pp. 105-122. "Structure Activity Studies on Maganins and Other Host Defense Peptides".
Goodbody Anne
Peers Susan H.
Pollak Alfred
Thornback John
Jones Dameron L.
Kight John
Resolution Pharmaceuticals Inc.
LandOfFree
Non-receptor mediated imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-receptor mediated imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-receptor mediated imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1563611